Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect.

  • Authors : Heifets BD; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California.; Williams NR

Subjects: Alcoholism* ; Ketamine*; Antidepressive Agents

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Jun 01; Vol. 76 (6), pp. 657-658.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Editorial & Opinion

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply.

  • Authors : Krystal JH; Department of Psychiatry, Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut.; Yoon G

Subjects: Alcoholism* ; Ketamine*; Antidepressive Agents

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Jun 01; Vol. 76 (6), pp. 658-659.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.

  • Authors : Yoon G; Department of Psychiatry, VA Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut.; Petrakis IL

Subjects: Alcoholism/Alcoholism/Alcoholism/*drug therapy ; Depressive Disorder, Major/Depressive Disorder, Major/Depressive Disorder, Major/*drug therapy ; Ketamine/Ketamine/Ketamine/*therapeutic use

  • Source: JAMA psychiatry [JAMA Psychiatry] 2019 Mar 01; Vol. 76 (3), pp. 337-338.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children: The PRIME Randomized Clinical Trial.

  • Authors : Frey TM; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Subjects: Analgesics/Analgesics/Analgesics/*administration & dosage ; Extremities/Extremities/Extremities/*injuries ; Fentanyl/Fentanyl/Fentanyl/*administration & dosage

  • Source: JAMA pediatrics [JAMA Pediatr] 2019 Feb 01; Vol. 173 (2), pp. 140-146.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print

Record details

×
Editorial & Opinion

Adjunctive Intranasal Esketamine in Treatment-Resistant Depression-Reply.

  • Authors : Daly EJ; Department of Neuroscience, Janssen Research & Development, LLC, Titusville, New Jersey.; Singh JB

Subjects: Depressive Disorder, Treatment-Resistant* ; Ketamine*; Administration, Intranasal

  • Source: JAMA psychiatry [JAMA Psychiatry] 2018 Jun 01; Vol. 75 (6), pp. 654-655.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Editorial & Opinion

Adjunctive Intranasal Esketamine in Treatment-Resistant Depression.

  • Authors : Shouan A; Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Grover S

Subjects: Depressive Disorder, Treatment-Resistant* ; Ketamine*; Administration, Intranasal

  • Source: JAMA psychiatry [JAMA Psychiatry] 2018 Jun 01; Vol. 75 (6), pp. 654.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders.

  • Authors : Wilkinson ST; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.; The Yale Psychiatric Hospital, Yale New Haven Health, New Haven, Connecticut.

Subjects: Off-Label Use*; Anesthetics, Dissociative/Anesthetics, Dissociative/Anesthetics, Dissociative/*therapeutic use ; Ketamine/Ketamine/Ketamine/*therapeutic use

  • Source: JAMA [JAMA] 2017 Sep 05; Vol. 318 (9), pp. 793-794.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Ketamine for the Treatment of Depression.

  • Authors : Kraus C; Neuroimaging Labs, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.; Lanzenberger R

Subjects: Depression* ; Ketamine*; Consensus

  • Source: JAMA psychiatry [JAMA Psychiatry] 2017 Sep 01; Vol. 74 (9), pp. 970.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
Academic Journal

Ketamine for the Treatment of Depression.

  • Authors : Golzari SEJ; Research Center for Evidence-Based Medicine, Tabriz University of the Medical Sciences, Tabriz, Iran.; Department of Anesthesiology and Intensive Care Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Subjects: Depression* ; Ketamine*; Consensus

  • Source: JAMA psychiatry [JAMA Psychiatry] 2017 Sep 01; Vol. 74 (9), pp. 971.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

×
  • 1-10 of  180 results for ""KETAMINE""